Avidity Biosciences
RNA
#1844
Rank
NZ$18.77 B
Marketcap
NZ$121.57
Share price
-0.29%
Change (1 day)
105.96%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: NZ$18.77 Billion

As of February 2026 Avidity Biosciences has a market cap of NZ$18.77 Billion. This makes Avidity Biosciences the world's 1844th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$18.77 B0.07%
2025NZ$18.76 B194.61%
2024NZ$6.36 B462.18%
2023NZ$1.13 B-51.22%
2022NZ$2.32 B42.33%
2021NZ$1.63 B22.96%
2020NZ$1.32 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Avidity Biosciences was reported to be:

NZ$18.31 Billion
by Nasdaq info icon info icon
NZ$18.77 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$254.53 B 1,255.41%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$193.00 B 927.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$3.45 B-81.60%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ$9.92 B-47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.22 B-98.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.37 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$18.27 B-2.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$5.14 B-72.58%๐Ÿ‡บ๐Ÿ‡ธ USA